Muscle and strength in midlife: what changes with age

Muscle and strength are often discussed as if they were one measurement. They are related, but each describes something different. Keeping those differences in view helps make sense of age-related findings—and avoids treating menopause, aging, and an individual experience as interchangeable explanations.

Five related measures, five different questions

Muscle mass describes how much muscle tissue a person has. It is a measure of quantity, not a direct test of what that muscle can do.

Muscle strength is the force a muscle or group of muscles can produce. Grip strength is one practical test, but it measures a particular action and is not a complete measure of whole-body strength.

Muscle power includes how quickly force can be produced. It can matter for quick movements, but it cannot be inferred from muscle mass or a grip test alone.

Physical performance describes how a person completes a task, such as rising from a chair or walking. The result can reflect strength and power along with balance, coordination, pain, health, confidence, and the testing conditions.

Bone density measures mineral content in specific bones, commonly with a DEXA scan. It is not a muscle measurement or a test of movement. The two systems are connected in the body, but a bone-density result cannot stand in for strength or function.

What research says about age-related change

Research across adulthood finds that muscle size and strength tend to be lower at older ages, on average. A quantitative review found that strength often declined faster than muscle size in the studies that measured both. This distinction is one reason researchers use the term dynapenia for loss of strength, separate from sarcopenia, which is assessed using strength, muscle quantity or quality, and physical performance.

Those broad patterns do not describe a fixed timetable for each person. The review’s age comparisons often contrasted younger adults with adults over 65, and some reported rates came from people around age 75. Differences in the people studied and in how muscle was measured also affected the estimates. This is useful evidence about older adulthood, but it cannot provide a reliable rate of change for women in their 40s or 50s.

The EWGSOP2 consensus likewise treats low strength, muscle quantity or quality, and physical performance as distinct parts of sarcopenia assessment. Its definitions help researchers and clinicians use consistent terms, but the consensus focuses on sarcopenia, a muscle disease seen most often in older adults. It does not mean that ordinary changes in midlife are sarcopenia, or that a single grip or body-composition result can diagnose it.

What a study of midlife women found

A longitudinal analysis from the Chicago site of the Study of Women’s Health Across the Nation (SWAN) followed 563 women and assessed three-year changes in grip and pinch strength. Women who became postmenopausal had an adjusted 0.57 kg greater decline in pinch strength than women who remained premenopausal. The estimated grip-strength difference was 1.04 kg, but it was not statistically clear. The study also reported smaller differences for some women who entered perimenopause.

This is direct evidence about midlife women and specific hand-strength tests. It is an observational association: the study cannot show that menopause caused the differences. It came from one SWAN site, followed a limited period, and did not measure whole-body muscle mass, power, or everyday physical performance. Its results should not be treated as a forecast for an individual woman.

Aging and menopause are not the same exposure

Age changes over time for everyone; menopausal status changes during a particular transition. They can occur together, which makes it difficult for a study to separate their contributions. The SWAN analysis is relevant to the transition, but its design does not establish a menopause-specific mechanism. Meanwhile, much of the wider age-related muscle literature focuses on older adults rather than following women through midlife.

Important questions remain: how muscle mass, strength, power, and task performance change across the menopause transition; whether those trajectories differ from changes with age alone; and how they vary across women with different health histories and activity levels. Larger, longer studies using several measures would help answer those questions. Until then, evidence from older adults should be labeled as indirect for women over 40, and menopause-related findings should be described as associations when the study design cannot establish cause.

Educational scope: This guide summarizes population research and consensus definitions. It cannot diagnose a muscle condition or explain an individual change in strength or function.